BioMagnetic Solutions is currently developing its FEOSS™ (Ferrofluid-Enabled One-Step Separation) system for cell separation applications for the biopharma research market. The patent-pending technology ofFEOSS™ revolutionizes the way in which cell separations are performed, allowing magnetically labeled target cells to be lifted right out of solution and recovered with extremely high purity (≥98%), viability (>99%) and high yields.
FEOSS™ isolated cells can be analyzed directly on theFEOSS™ collection surface, or alternatively, captured cells can be retrieved for further downstream processing. In short,FEOSS™ produces better cell separation results (yield, purity, and viability) much more rapidly than competing cell separation methods with drastically less cell manipulation which translates into healthier cells for biomedical research.